Market Place
Sourcing Support
SEQENS Unit Joins Smart Immune for Clinical Batch Making
03 Dec 2024 //
PRESS RELEASE
Smart Immune, CELLforCURE Partner For Clinical Manufacturing
02 Dec 2024 //
GLOBENEWSWIRE
Smart Immune Announces Recommended SMART101 Dose For Trials
23 Oct 2024 //
GLOBENEWSWIRE
Smart Immune Treats Leukemia Patient At Final Phase 1/2 Dose
02 May 2024 //
GLOBENEWSWIRE
Smart Immune appoints key new members to its Board of Directors
16 Feb 2024 //
GLOBENEWSWIRE
Smart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer
04 Dec 2023 //
GLOBENEWSWIRE
Smart Immune targets $54M Series A to advance T cell progenitor therapy
15 Nov 2023 //
ENDPTS
Smart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform
10 Nov 2023 //
GLOBENEWSWIRE
Smart Immune to Present Details of Pioneering Study at ASH Annual Meeting 2023
02 Nov 2023 //
GLOBENEWSWIRE
Smart Immune Showcases Data and Presentations at ESGCT
12 Oct 2023 //
GLOBENEWSWIRE
Smart Immune Doses First Leukemia Patients with ProTcell Therapy SMART101
27 Sep 2023 //
GLOBENEWSWIRE
Smart Immune to present details of phase I/II studies of T-cell therapy SMART101
11 May 2023 //
GLOBENEWSWIRE
Smart Immune receives 2.5m grant and 15m equity investment commitment from EIC
30 Mar 2023 //
GLOBENEWSWIRE
Smart Immune is selected for first cohort of the French Tech Health20 program
27 Mar 2023 //
GLOBENEWSWIRE
Smart Immune appoints world-class Clinical Advisory Board
21 Nov 2022 //
GLOBENEWSWIRE
Smart Immune appoints world-leading experts to its Scientific Advisory Board
28 Jul 2022 //
GLOBENEWSWIRE
Smart Immune Announces Oral Presentation of Cell-Fate Plasticity Data
20 May 2022 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.